Addressing the Innovation Gap: Policy Reform for the Inclusion of the Cannabis Industry in the Colorado Enterprise Zone Research and Development Tax Credit Framework

Introduction

The state of Colorado has long been recognized as a global leader in the regulated cannabis market, a position established through a decade of rigorous legislative oversight, sophisticated enforcement, and a commitment to public safety. However, as the industry matures and enters a period of stabilization characterized by declining tax revenues and increased interstate competition, a critical misalignment has emerged within the state’s fiscal policy. While Colorado has aggressively promoted itself as a hub for high-growth innovation, particularly in the fields of biotechnology, agricultural technology, and software development, a significant portion of its domestic business base—those involved in the legal marijuana sector—is explicitly barred from accessing one of the state’s most effective economic development tools: the Enterprise Zone (EZ) Research and Development (R&D) Tax Credit. This exclusion, rooted in a statutory requirement for dual compliance with both state and federal law, creates a profound disadvantage for small to medium-sized businesses (SMBs) operating in economically distressed areas of the state.

The Statutory Framework of Colorado’s Enterprise Zone Credits

The Colorado Urban and Rural Enterprise Zone Act was enacted in 1986 with the specific intent of revitalizing local economies that demonstrate chronic distress through high unemployment, low per capita income, or stagnant population growth.¹ The program empowers 16 designated enterprise zones to offer a suite of tax incentives designed to lower the cost of doing business and encourage the creation of high-wage jobs.² These zones are not static; they are periodically reviewed based on American Community Survey (ACS) 5-year data to ensure they continue to meet specific benchmarks of economic hardship.²

Economic Distress Benchmarks and Eligibility

To qualify for designation, a region must meet at least one of several criteria that signal economic underperformance relative to the state average. These metrics ensure that the tax credits are targeted where they can provide the greatest marginal utility for community revitalization.

Table 1: Enterprise Zone Designation Benchmarks

Within these zones, the R&D tax credit provides a powerful incentive for technical advancement. Under Section 39-30-105.5, C.R.S., a taxpayer who makes expenditures in research and experimental activities—as defined by Section 174 of the federal Internal Revenue Code (IRC)—is allowed a credit against their Colorado income tax.⁴ The credit is calculated as 3% of the increase in the business’s annual research and development expenses compared to the average of the previous two tax years.¹

The Mechanics of the R&D Credit

The credit is non-refundable but carries significant flexibility for long-term business planning. Taxpayers are required to claim 25% of the earned credit each year over a four-year period, and any excess beyond the taxpayer’s liability can be carried forward indefinitely.¹ This structure is particularly beneficial for SMBs that may be in a pre-revenue or low-profit phase during intense R&D cycles but expect to have higher tax liabilities as their innovations go to market. To claim the credit, a business must first pre-certify each location with the local Enterprise Zone Administrator, ensuring that the intended activity contributes to the economic development goals of the zone.¹

Table 2: EZ R&D Credit Specifications

The scope of “qualified research” is intentionally broad to encompass various forms of industrial and scientific progress. It must be technological in nature, intended to develop a new or improved product or process, and rely on a process of experimentation.¹ Despite this broad intent, the administrative guidelines explicitly state that businesses in the marijuana industry do not qualify because they must be legal under both state and federal law.¹

The Policy Issue: Categorical Exclusion and the Federal Shadow

The primary barrier to equity in Colorado’s innovation framework is the classification of marijuana as a Schedule I controlled substance under the federal Controlled Substances Act. This federal status casts a long shadow over state-level tax policy, often resulting in “shadow regulations” that penalize compliant state businesses.⁹

The Dual Legality Clause

The requirement that an eligible business must be “legal under both state and federal law” is an administrative hurdle that has not been modernized to reflect Colorado’s constitutional and statutory embrace of the marijuana industry.¹ While the state has legalized both medical and recreational marijuana, and the Department of Revenue (DOR) and Marijuana Enforcement Division (MED) meticulously regulate thousands of licensees, the Enterprise Zone program continues to use federal illegality as a disqualifying factor for high-growth incentives.¹ This exclusion represents a significant policy contradiction: the state collects hundreds of millions of dollars in excise and sales taxes from these businesses but denies them the very incentives it uses to attract other “high-growth” industries like aerospace or biotechnology.⁵

The Crushing Burden of IRC Section 280E

The exclusion from the EZ R&D credit is compounded by the federal tax treatment of the industry under IRC Section 280E. This provision prohibits businesses from deducting ordinary and necessary business expenses if they are involved in the “trafficking” of Schedule I or II substances.⁹ For a standard business, taxable income is calculated as gross receipts minus all business expenses, including rent, utilities, payroll, and R&D costs. However, for a marijuana business, Section 280E limits deductions almost exclusively to the Cost of Goods Sold (COGS)—the direct costs of producing the inventory.⁹

This results in an effective tax rate that is disproportionately high, as businesses are taxed on their gross profit rather than their net income.⁹ A marijuana business with $100,000 in revenue and $80,000 in expenses (including rent, utilities, and R&D labor) might only be able to deduct $40,000 in COGS. While a normal business would pay tax on $20,000 of net income, the marijuana business would owe tax on $60,000, leading to a scenario where the business could have a negative cash flow despite being operationally profitable.⁹

Table 3: The 280E Tax Burden Calculation

Note: Calculations based on the hypothetical $100k revenue model described in research materials.⁹

Because Section 280E specifically targets Schedule I and II substances, the denial of R&D credits at the federal level is a known hurdle. However, several states have begun to decouple their tax codes from these federal restrictions to support their local industries.¹³ Colorado has already done this for general business expenses under Sections 39-22-304(3)(m) and 39-22-104(4)(r), C.R.S., but it has stopped short of extending this decoupling to the Enterprise Zone credits.¹⁷ This leaves Colorado cannabis SMBs in a state of fiscal limbo—recognized as legal and deductible for basic operations, but “illegal” and excluded for innovation.

The Economic Context of the Colorado Cannabis Market

The urgency for policy reform is underscored by the current economic trajectory of the marijuana industry in Colorado. The market has shifted from a phase of explosive, unregulated growth to one of maturity and increased competition.

Revenue Decline and Market Saturation

For the first eight years of legalization, Colorado saw consistent growth in marijuana tax revenue, peaking at $424.4 million in Fiscal Year (FY) 2020-21.¹⁸ Since that peak, revenue has declined annually, dropping to approximately $231.1 million in FY 2024-25—a decline of more than 45%.¹⁸ This downward trend is not merely a “market correction” but a structural shift driven by three primary factors: interstate competition as nearly half of U.S. states have legalized adult use, a saturated domestic retail environment, and the proliferation of intoxicating hemp products that compete for consumer dollars while facing fewer regulatory burdens.¹⁸

Table 4: Colorado Marijuana Tax Revenue Trends

In this environment, the “commodity” phase of the marijuana industry is ending. To survive, businesses must pivot toward value-added products and operational efficiencies that can only be achieved through research and development. However, the current exclusion from EZ R&D credits means that SMBs, which are the most vulnerable to these market shifts, lack the capital to make these necessary investments.⁹

The Vulnerability of SMBs in Distressed Zones

Large multi-state operators (MSOs) often have the capital reserves to weather the high effective tax rates of 280E or can utilize complex corporate structures to isolate non-plant-touching activities, such as software development or branding, into separate entities that can claim deductions.⁹ SMBs, particularly those located in rural or economically distressed urban enterprise zones, rarely have the legal or accounting resources to execute these maneuvers. As a result, the exclusion of the industry from EZ credits disproportionately harms the very businesses the Enterprise Zone program was designed to protect: local entrepreneurs trying to build sustainable companies in underserved communities.²

The Horizon of Innovation: R&D Potential in Cannabis

The exclusion is particularly counter-intuitive given the high intensity of research currently occurring within the Colorado cannabis sector. The industry is a nexus of several “high-growth” fields, and the innovations being developed here have broad applications beyond the marijuana market itself.

Agricultural Technology (Ag-Tech)

Cultivation is no longer a matter of simple horticulture; it is increasingly a field of advanced agricultural engineering. R&D in this space includes the development of automated nutrient delivery systems, climate-controlled environments that utilize artificial intelligence to optimize VPD (vapor pressure deficit), and novel water reclamation technologies.⁷ For instance, innovations in “curing” technology—traditionally a labor-intensive process involving “burping” glass jars—are now moving toward automated, pharmaceutical-grade systems that apply food science to preserve terpene stability and prevent microbial growth.²²

The science of water activity (aw) is a critical R&D area. If the water activity in the flower drops below 0.6, terpenes begin to degrade; if it rises too high, the risk of mold increases significantly.²² Developing automated systems to maintain this delicate balance is a “qualified research activity” that involves experimentation and technical uncertainty, yet it is currently ineligible for the EZ R&D credit.¹

Pharmaceutical Grade Extraction and Stability

The transition of cannabis from a recreational product to a medically precise one requires significant R&D in extraction and purification. SMBs are currently researching novel solventless extraction techniques, the stabilization of rare cannabinoids like THCV or CBC, and advanced delivery mechanisms such as nano-emulsions for infused beverages or transdermal patches.⁷ Furthermore, the industry is borrowing from the pharmaceutical world to develop “passive modified atmospheric packaging,” which uses nine-layer film technology to extend shelf life and potency during transport—a critical innovation for the future of interstate and international commerce.²²

Software and Compliance Systems

The regulatory complexity of the Colorado market has birthed a specialized software sub-sector. R&D in this field involves creating custom Enterprise Resource Planning (ERP) solutions and inventory management tools that integrate directly with the state’s Metrc tracking system.⁷ These systems must solve complex algorithmic problems related to batch tracking, tax calculation, and multi-jurisdictional compliance.²¹ This is “software development” in its purest sense, a classic qualifying category for R&D credits, yet because the end product is intended for the marijuana industry, the developers may be barred from EZ credits if they are vertically integrated with a licensee.¹

Table 5: Qualified Research Activities in the Cannabis Sector

Solution 1: Statutory Decoupling and Administrative Alignment

The first and most direct solution for the Colorado Legislature is to amend the state’s Enterprise Zone statutes to explicitly decouple the definition of an “eligible business” from federal legality. This would bring the EZ program into alignment with the state’s existing income tax policy regarding business expense deductions.

Legislative Amendment to Section 39-30-101 et seq.

The legislature should amend the Urban and Rural Enterprise Zone Act to state that for the purposes of Enterprise Zone tax credits, a business shall be considered “legal” if it holds a valid license issued by the Colorado Marijuana Enforcement Division and is in good standing with the Department of Revenue.¹ Specifically, Section 39-30-105.5, C.R.S., which governs the R&D credit, should be amended to include a provision that “qualified research and experimental activities” include those conducted by licensed marijuana businesses, notwithstanding their status under federal law.⁴

Removing the “Dual Legality” Administrative Barrier

Currently, the Office of Economic Development and International Trade (OEDIT) enforces the federal legality requirement as a matter of administrative policy derived from the general intent of the statute.¹ By clarifying the statute, the legislature provides OEDIT and the local Enterprise Zone Administrators with the clear authority to process pre-certification applications for marijuana businesses.⁶ This would allow these businesses to enter the same “pipeline” of innovation support as any other tech-driven company in the state.

This solution is highly practical because it utilizes existing infrastructure. It does not require the creation of a new state agency or a complex new tax form. It simply allows a significant and technologically intensive sector of the Colorado economy to access a 3% credit for their incremental R&D increases—incentivizing them to hire more scientists, engineers, and technicians within distressed zones.¹

Solution 2: The “Cannabis Innovation and Equity” Accelerator Credit

A second, more targeted solution would be to create a specialized innovation credit within the framework of the already-existing Marijuana Entrepreneur Fund. This approach would focus specifically on SMBs and social equity licensees, addressing both the innovation gap and the state’s goals for social equity in the industry.

Integration with the Marijuana Entrepreneur Fund

The legislature has already established the Marijuana Entrepreneur Fund under Section 24-48.5-128, C.R.S., which is designed to provide grants, loans, and technical assistance to entrepreneurs in the marijuana industry, with a priority for social equity licensees.²⁹ This fund was initially seeded with $4 million from the Marijuana Tax Cash Fund (MTCF).²⁹

A new “Innovation and Equity Accelerator Credit” could be modeled after the proposed (though previously postponed) HB24-1061, which sought to create tax credits for accelerator-endorsed licensees who provide technical and capital support to social equity participants.³¹ By repurposing this logic into an R&D-specific credit, the state could allow a 3% to 5% credit for R&D expenditures specifically for:

• Social equity licensees conducting their own research.
• Established businesses that partner with social equity licensees to develop new technologies.³¹

Specialized Oversight and Technical Peer Review

One of the challenges of the general EZ R&D credit is that local EZ Administrators may lack the technical expertise to evaluate the “process of experimentation” in complex cannabis science.¹ By housing a specialized credit within the Marijuana Entrepreneur Fund framework, the state could utilize the expertise of the Medical Marijuana Scientific Advisory Council (SAC).²⁶ The SAC already provides scientific peer-review for research proposals and could be tasked with certifying that a business’s R&D activities meet the “technological in nature” requirement before the tax credit is granted.³³

This solution has the advantage of being “funded” by the industry itself, as the MTCF is comprised of revenue from the special sales and excise taxes on marijuana.¹⁹ It ensures that the tax revenue generated by the industry is reinvested back into the industry’s long-term sustainability and technological leadership.

Implementation, Fraud Prevention, and Oversight

A critical concern for the state government in implementing these policy changes is the potential for fraud, wastage, or the “re-labeling” of ordinary business expenses as R&D to claim a tax benefit. This is a common challenge for R&D tax credits in all industries, but the unique regulatory status of marijuana provides the state with superior tools for oversight.

Leveraging the Metrc Audit Trail

Colorado’s “seed-to-sale” tracking system, Metrc, is one of the most sophisticated inventory management tools in any regulated industry.³⁷ Every plant, batch of concentrate, and final product is assigned a unique Radio Frequency Identification (RFID) tag.³⁷ For R&D purposes, the MED already requires specific “Research and Development” licenses that allow facilities to possess and process cannabis for scientific investigation rather than commercial sale.²⁶

To prevent fraud, the government could require that any business claiming the R&D credit must maintain an “R&D Log” within the Metrc system, documenting which plant materials and labor hours were dedicated to specific experimental batches.²⁵ This creates a digital audit trail that far exceeds the documentation typically required of non-marijuana businesses claiming the R&D credit, making it significantly harder to “hide” ordinary production costs as R&D.⁹

The Role of the Scientific Advisory Council (SAC)

The Medical Marijuana Scientific Advisory Council (SAC), established under Section 25-1.5-106.5, C.R.S., is composed of experts in toxicology, epidemiology, and pharmacology.³³ Its existing duty is to provide peer-review for research proposals funded by state grants.³³ For the R&D tax credit, the SAC could be utilized as a “Technical Certification Board.”

Table 6: Proposed Multi-Agency Oversight Framework

SMB-Specific Protections

To ensure the policy change benefits SMBs rather than just large corporate entities, the legislature can implement a “size-based” verification process. Similar to the federal R&D payroll tax offset, the state could limit the credit to businesses with less than $5 million in annual gross receipts or those in their first five years of operation.⁵ Additionally, require that a certain percentage of the R&D labor must be performed by U.S.-based (and specifically Colorado-based) employees to prevent the “offshoring” of innovation benefits.⁵

Cost Analysis and the Investment in Future Benefits

A common hurdle for any tax policy change is the initial fiscal impact on the state’s General Fund. However, the proposed changes for the cannabis industry should be framed not as a “cost,” but as a strategic reinvestment with a high multiplier effect.

Estimating the Initial Outlay

The cost of the 3% EZ R&D credit is naturally limited because it only applies to the increase in R&D spending over the prior two years.¹ If a business spends $100,000 on R&D for three consecutive years, they earn zero credit. They only earn a credit if they increase their investment.

Based on the 2018 fiscal impact of the Marijuana Business Expense Deduction, which was approximately $10.6 million for 488 taxpayers, the impact of an R&D-specific credit would be significantly smaller.¹⁷ Given that R&D is only a subset of total business expenses, and that the credit is only 3% of the increase, the annual revenue reduction is estimated to be between $1 million and $2.5 million statewide.³²

Table 7: Estimated Fiscal Impact of Cannabis EZ R&D Inclusion

The “Future Benefits” Multiplier

The initial outlay will be recouped over time through the expansion of the broader tax base and the creation of a “Colorado-First” intellectual property (IP) engine.

• Industrial Efficiency and Energy Savings: Marijuana cultivation is energy-intensive, accounting for roughly 2% of Colorado’s total electricity use.²¹ R&D into more efficient HVAC and lighting systems directly reduces cultivators’ operating costs. As these costs fall, their net income rises, leading to higher corporate income tax collections that will eventually exceed the value of the 3% credit.⁷
• Intellectual Property and Licensing Revenue: When a Colorado SMB develops a new stable cannabinoid formulation or a more effective pest-control technology (like the RF-based “Canna-Wave”), they can patent and license that technology to other states and countries.²² This brings “new money” into the Colorado economy that is not dependent on local retail sales. The state can tax the licensing income of these Colorado-based IP holders.⁹
• Preserving the Retail Tax Base: The decline in marijuana tax revenue is partly due to a lack of product differentiation.¹⁸ By incentivizing R&D, the state helps the legal market produce superior, safer, and more innovative products that the illicit market cannot replicate. This stabilizes retail demand and protects the hundreds of millions of dollars in 15% special sales tax revenue the state relies on for the Public School Fund.¹⁸

If the R&D credit helps stabilize the industry such that it prevents even a 1% further decline in annual sales, it preserves approximately $10 million in market value and nearly $1.5 million in special sales tax revenue—effectively paying for the entire R&D program in a single year.¹⁸

The Importance of Policy Change and the Cost of Inaction

The exclusion of the marijuana industry from the EZ R&D framework is not a neutral policy; it is a choice that actively degrades Colorado’s competitive advantage and threatens its economic stability.

The Consequences of Inaction: “Innovation Atrophy”

If Colorado maintains the status quo, the state risks “Innovation Atrophy.” As other states like California and Minnesota implement specific R&D incentives and modify their tax codes to favor the cannabis sector, Colorado’s top scientific and technical talent will migrate to more favorable environments.⁴¹ SMBs in the Front Range or Pueblo that have spent a decade building expertise will find it more cost-effective to move their research labs to jurisdictions that treat them as legitimate partners in innovation.²⁰

Erosion of Rural Economic Resilience

For many rural Colorado counties, the marijuana industry is one of the few high-growth sectors providing year-round, non-seasonal employment in an era of agricultural consolidation.² Without access to EZ credits, these rural businesses are less likely to invest in the expensive infrastructure (like climate-controlled, energy-efficient greenhouses) required to compete with large-scale industrial grows.²⁰ When these rural SMBs fail, the economic distress in those enterprise zones will deepen, increasing the state’s long-term burden for unemployment and social services.²

The Threat of Illicit Market Resurgence

The most dangerous consequence of stifling legal innovation is the empowerment of the illicit market. Legal businesses must bear the costs of testing, child-resistant packaging, and heavy taxation.¹³ Their only competitive edge is the ability to offer innovative, safe, and regulated products that the “underground” market cannot match.⁷ By denying these businesses the same R&D support provided to other industries, the state effectively increases the cost of the “legal” product relative to the “illegal” one. This pushes consumers back to unregulated sellers, leading to a further death spiral of declining tax revenue and increased public health risks.¹⁸

Conclusion: A Strategic Pivot for the Next Decade

Colorado is at a critical juncture. The “early mover” advantage it once held in the marijuana industry has dissipated as legalization spreads across the continent. To maintain its leadership and ensure the long-term stability of its tax revenues, the state must transition from a policy focused primarily on “taxation and enforcement” to one that includes “innovation and incentive.”

The Enterprise Zone R&D credit is an existing, proven tool that is perfectly suited for this transition. By removing the categorical exclusion of marijuana businesses and implementing the rigorous oversight mechanisms already available through the MED, Metrc, and the Scientific Advisory Council, the state can foster a new era of “Cannabis 2.0.” This will be an era defined not by bulk commodity production, but by pharmaceutical-grade precision, agricultural sustainability, and the creation of valuable intellectual property.

The investment required is modest; the potential for fraud is mitigated by unparalleled regulatory visibility; and the future benefits—in the form of high-wage jobs, energy efficiency, and tax base preservation—are substantial. For the benefit of the thousands of small businesses that have helped build this industry, and for the economic health of the distressed communities they support, the Colorado Legislature must act to bridge the innovation gap and treat the legal marijuana industry as the high-growth, high-tech sector it has truly become.

Works Cited

1. Enterprise Zone Research and Development Tax Credit | Colorado …, accessed on March 16, 2026, https://oedit.colorado.gov/enterprise-zone-research-and-development-tax-credit
2. Enterprise Zone Program | Colorado Office of Economic Development and International Trade, accessed on March 16, 2026, https://oedit.colorado.gov/enterprise-zone-program
3. 2024 Colorado Revised Statutes Title 39, , , Article 30 – URBAN AND RURAL ENTERPRISE ZONE ACT – Justia Law, accessed on March 16, 2026, https://law.justia.com/codes/colorado/title-39/specific-taxes/enterprise-zones/article-30/
4. Colorado Revised Statutes Title 39. Taxation § 39-30-105.5 – Codes – FindLaw, accessed on March 16, 2026, https://codes.findlaw.com/co/title-39-taxation/co-rev-st-sect-39-30-105-5/
5. Colorado R&D Tax Credit Services – TaxTaker, accessed on March 16, 2026, https://www.taxtaker.com/rd-tax-credit/colorado
6. Enterprise Zone Tax Guide | Department of Revenue – Colorado tax, accessed on March 16, 2026, https://tax.colorado.gov/enterprise-zone-tax-guide
7. The R&D Tax Credit is an Untapped Resource in the Cannabis Industry | CBIZ, accessed on March 16, 2026, https://www.cbiz.com/insights/article/research-and-development-tax-credit-cannabis-industry
8. Enterprise Zone Investment Tax Credit | Colorado Office of Economic Development and International Trade, accessed on March 16, 2026, https://oedit.colorado.gov/enterprise-zone-investment-tax-credit
9. Rescheduling marijuana would be a big tax break for legal cannabis businesses – and a quiet form of deregulation | Colorado Law, accessed on March 16, 2026, https://www.colorado.edu/law/2026/02/02/rescheduling-marijuana-would-be-big-tax-break-legal-cannabis-businesses-and-quiet-form
10. Marijuana Taxes | Department of Revenue – Taxation, accessed on March 16, 2026, https://tax.colorado.gov/marijuana-taxes
11. Marijuana Tax Reports | Colorado Department of Revenue, accessed on March 16, 2026, https://cdor.colorado.gov/data-and-reports/marijuana-data/marijuana-tax-reports
12. Marijuana Sales Near $1B, Raising Almost $200M of Tax Revenue in 2025, accessed on March 16, 2026, https://governorsoffice.colorado.gov/governor/news/marijuana-sales-near-1b-raising-almost-200m-tax-revenue-2025
13. States Allowing State-Legal Cannabis Business Expenses Deductions Despite 280E, accessed on March 16, 2026, https://www.mpp.org/issues/legalization/states-allowing-state-legal-cannabis-business-expenses-deductions-despite-280e/
14. Marijuana Business Tax Blues in Oregon, Washington, California & Colorado, accessed on March 16, 2026, https://www.taxfortress.com/marijuana-business-tax-blues-in-oregon-washington-california-colorado/
15. Cannabis tax compliance: Planning for rescheduling – CohnReznick, accessed on March 16, 2026, https://www.cohnreznick.com/insights/cannabis-tax-compliance-planning-for-potential-rescheduling
16. Tax Credits for Cannabis Businesses: Maximizing Your Savings Potential – Redbud Advisors, accessed on March 16, 2026, https://www.redbudadvisors.com/post/tax-credits-for-cannabis-businesses-maximizing-your-savings-potential
17. MARIJUANA RELATED TAX EXPENDITURES – Agencies – Colorado, accessed on March 16, 2026, https://content.leg.colorado.gov/sites/default/files/te_37_marijuana_related_tax_expenditures.pdf
18. Colorado Marijuana Revenue Is Declining As Other States Legalize, But It Still Outpaces Alcohol Taxes, Report Shows, accessed on March 16, 2026, https://www.marijuanamoment.net/colorado-marijuana-revenue-is-declining-as-other-states-legalize-but-it-still-outpaces-alcohol-taxes-report-shows/
19. Marijuana Revenue in the State Budget – Agencies – Colorado, accessed on March 16, 2026, https://content.leg.colorado.gov/sites/default/files/r25-569-update-marijuana-in-the-state-budget-memo-accessible.pdf
20. Colorado Legal Cannabis Market Size, Growth and Forecast Report 2030F, accessed on March 16, 2026, https://www.techsciresearch.com/report/colorado-legal-cannabis-market/29170.html
21. Colorado Legal Cannabis Market Size | Industry Report, 2030 – Grand View Research, accessed on March 16, 2026, https://www.grandviewresearch.com/industry-analysis/colorado-legal-cannabis-market-report
22. The science behind curing and packaging cannabis for a global market, accessed on March 16, 2026, https://mjbizdaily.com/news/the-science-behind-curing-and-packaging-cannabis-for-a-global-market/614019/
23. How Big Pharma Plans to Destroy the Cannabis Industry As We Know It, accessed on March 16, 2026, https://cannatechtoday.com/how-big-pharma-plans-to-destroy-the-cannabis-industry-as-we-know-it/
24. The Future of Cannabis Packaging to 2024 | Market Report, Trends and Data – Smithers, accessed on March 16, 2026, https://www.smithers.com/resources/2020/may/smithers-forecasts-global-cannabis-packaging-marke
25. DR 8548 Regulated Marijuana Business License Application – Marijuana Enforcement Division – Colorado, accessed on March 16, 2026, https://med.colorado.gov/sites/med/files/documents/DR%208548e%20ADA%20RMB%20New%20app%207-2025%20.pdf
26. Colorado Marijuana Research License | ColoradoCannabis.org, accessed on March 16, 2026, https://coloradocannabis.org/licensing/research
27. Agrotech – MediCane, accessed on March 16, 2026, https://medicane.net/agrotech/
28. The Colorado Office of Economic Development and International Trade Annual Report Fiscal Year 2023-2024, accessed on March 16, 2026, https://oedit.colorado.gov/sites/coedit/files/documents/FINALAnnualReport_2024_12-19.pdf
29. REVISED – Colorado General Assembly – Colorado.gov, accessed on March 16, 2026, http://leg.colorado.gov/bill_files/51604/download
30. CO SB076 – BillTrack50, accessed on March 16, 2026, https://www.billtrack50.com/billdetail/1798702
31. HB24-1061 Marijuana Industry & Social Equity – Colorado General Assembly, accessed on March 16, 2026, http://leg.colorado.gov/bills/hb24-1061
32. Fiscal Note – Colorado General Assembly, accessed on March 16, 2026, https://leg.colorado.gov/bill_files/41064/download
33. Medical Marijuana Scientific Advisory Council (SAC) | Colorado Department of Public Health and Environment, accessed on March 16, 2026, https://cdphe.colorado.gov/medical-marijuana-scientific-advisory-council-sac
34. Colorado Revised Statutes Section 44-10-507 (2024) – Marijuana research and development license – Justia Law, accessed on March 16, 2026, https://law.justia.com/codes/colorado/title-44/marijuana-regulation/article-10/part-5/section-44-10-507/
35. Colorado Revised Statutes Title 39. Taxation § 39-28.8-501 – Codes – FindLaw, accessed on March 16, 2026, https://codes.findlaw.com/co/title-39-taxation/co-rev-st-sect-39-28-8-501/
36. 39-28.8-501. Marijuana tax cash fund – creation – distribution – legislative declaration – repeal., accessed on March 16, 2026, https://www.lpdirect.net/casb/crs/39-28_8-501.html
37. Optimizing Colorado Cannabis Accounting Success 2025, accessed on March 16, 2026, https://nacatpros.org/west/colorado/colorado-cannabis-accounting-280e-2025
38. Keeping up in Colorado: What in-state manufacturers need to know about R&D tax rules, accessed on March 16, 2026, https://www.wipfli.com/insights/articles/keeping-up-in-colorado-what-in-state-manufacturers-need-to-know-about-r-and-d-tax-rules
39. Fiscal Note – Colorado General Assembly, accessed on March 16, 2026, http://leg.colorado.gov/bill_files/46041/download
40. Economic and Fiscal Impact Analysis 2026 Multi-Batch Product Regulations – CA.gov, accessed on March 16, 2026, https://cdn.cannabis.ca.gov/wp-content/uploads/sites/2/2026/02/2026-01-r-multipacks-20260227-isor.pdf
41. Cannabis | FTB.ca.gov, accessed on March 16, 2026, https://www.ftb.ca.gov/file/business/industries/cannabis.html
42. House fiscal analysts lay out budget impact of Chapter 13: data centers and cannabis drive revenue gains; R&D credit costs offset some gains | Citizen Portal, accessed on March 16, 2026, https://citizenportal.ai/articles/7511262/Minnesota/2026-Legislature-MN/House-fiscal-analysts-lay-out-budget-impact-of-Chapter-13-data-centers-and-cannabis-drive-revenue-gains-R-and-D-credit-costs-offset-some-gains